FORM DEF 14A

Company

Lexaria Bioscience Corp.

Filed

December 10, 2025

Period of Report

January 27, 2026

Accession Number

0001640334-25-002275

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →